Eye drops represent 74.0% of product type demand in 2026. The corneal ulcer treatment market was valued at USD 1.0 billion in 2025, is projected to reach USD 1.8 billion by 2036 and is forecast to post a 5.0% CAGR between 2026 and 2036, creating an incremental opportunity of USD 0.7 billion.